Calendrier des promotions Orthofix Medical Inc.
À propos de l'entreprise
Orthofix Medical Inc. работает как компания по производству медицинского оборудования и биологических препаратов в США, Италии, Германии, Великобритании, Бразилии и других странах. Он работает в двух сегментах: Global Spine и Global Extremities. Сегмент Global Spine производит, распространяет и предоставляет вспомогательные услуги для устройств стимуляторов роста костей, которые улучшают сращение костей, а также используются в качестве терапевтического лечения переломов позвоночника и аппендикулярного отростка.
Plus de détailsP/S | 1.91 |
---|---|
P/BV | 2.69 |
EV/EBITDA | 16.74 |
EBITDA | 0.0496 |
Цена ао | 17.44 |
Сайт | https://www.orthofix.com |
Выручка | 0.46 |
P/E | 331.13 |
Див.доход ао | 0 |
ISIN | US68752M1080 |
Число акций ао | 0.03673 млрд |
Валюта | usd |
IPO date | 1992-04-24 |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Валюта отчета | usd |
Changement de prix par jour: | 0% (15.58) |
---|---|
Changement de prix par semaine: | +3.25% (15.09) |
Changement de prix par mois: | -7.04% (16.76) |
Changement de prix sur 3 mois: | -3.47% (16.14) |
Changement de prix sur six mois: | +19.85% (13) |
Changement de prix par an: | +19.39% (13.05) |
Evolution du prix sur 3 ans: | -57.01% (36.24) |
Evolution du prix sur 5 ans: | -71.36% (54.4) |
Evolution des prix depuis le début de l'année: | +49.95% (10.39) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Établissements | Volume | Partager, % |
---|---|---|
Boone Capital Management LLC | 975 | 2.6 |
Armistice Capital, LLC | 4 | 9.86 |
Rubric Capital Management LP | 4 | 9.77 |
Blackrock Inc. | 3 | 8.78 |
Engine Capital Management, LP | 3 | 8.09 |
Morgan Stanley | 3 | 7.35 |
Vanguard Group Inc | 2 | 5.35 |
Paradigm Capital Management | 2 | 5.19 |
Newtyn Management, LLC | 1 | 3.39 |
State Street Corporation | 1 | 2.84 |
ETF | Partager, % | Rentabilité pour l'année, % | Dividendes, % |
---|---|---|---|
Avantis U.S Small Cap Equity ETF | 0.06942 | 27.774101036841 | 1.68271 |
Avantis U.S. Equity ETF | 0.0012 | 32.224830464267 | 1.59151 |
Dimensional U.S. Core Equity 2 ETF | 0.00069 | 30.755198832543 | 1.47098 |
Dimensional U.S. Targeted Value ETF | 0.00915 | 26.007247921552 | 1.93487 |
Dimensional US Core Equity Market ETF | 0.00099 | 30.983243755928 | 1.40618 |
Dimensional U.S. Equity ETF | 0.00317 | 31.530984204131 | 1.3557 |
WisdomTree U.S. SmallCap Fund | 0.02378 | 31.540809405381 | 1.80258 |
Fidelity MSCI Health Care Index ETF | 0.0093 | 13.390080209527 | 1.46057 |
Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.09091 | 31.359936575053 | 1.41955 |
ProShares Hedge Replication ETF | 0.00331 | 5.9237999659878 | 1.47892 |
Humankind US Stock ETF | 0.02813 | 18.809430395549 | 1.99919 |
iShares Micro-Cap ETF | 0.13845 | 36.318555985322 | 1.54048 |
iShares Russell 3000 ETF | 0.001 | 32.57283798366 | 1.43482 |
Nuveen ESG Small-Cap ETF | 0.02569 | 29.971671388102 | 1.41019 |
Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.03708 | 35.452103849597 | 1.75869 |
Schwab U.S. Small-Cap ETF | 0.01677 | 34.281650071124 | 1.51433 |
Schwab U.S. Broad Market ETF | 0.00101 | 32.5 | 1.43354 |
SPDR SSGA US Small Cap Low Volatility Index ETF | 0.05511 | 34.330540625988 | 2.97092 |
ProShares UltraPro Russell2000 | 0.01181 | 89.821266282945 | 1.47873 |
Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
Vanguard Russell 2000 ETF | 0.02 | 35.648084105685 | 1.48801 |
SPDR S&P Health Care Equipment ETF | 0.56713 | 24.103930712858 | 0.35622 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Ms. Jill Mason | Interim Chief Ethics & Compliance Officer and VP of Corporate Counsel | N/A | |
Mr. Ehab M. Esmail | Senior Vice President of Global Quality, Regulatory & Clinical Affairs | N/A | 1972 (52 année) |
Mr. Massimo Calafiore | President, CEO, Director and Interim President of Global Spine | N/A | 1972 (52 année) |
Ms. Julie B. Andrews | Chief Financial Officer | N/A | 1971 (53 année) |
Mr. Geoffrey C. Gillespie | VP & Corporate Controller | ||
Ms. Aviva McPherron | President of Global Operations & Quality | ||
Ms. Julie D. Dewey | Chief Investor Relations & Communications Officer | 1961 (63 année) | |
Mr. J. Andres Cedron | Chief Legal Officer & Corporate Secretary | 1981 (43 année) | |
Ms. Stephanie Walsh | Chief Human Resources Officer | ||
Mr. Tyler P. Lipschultz | President of Global Biologics | 1967 (57 années) |
Site web: https://www.orthofix.com